MESO action tonight, page-576

I don't necessarily think it's not going to be successful, and I hope it is.

But given how these trials generally pan out, with remdesmivir and hydroxychloroquine having good preliminary results and failing, with previous MSC companies targeting similar disease processes having successful phase 1 and 2 studies and failing phase 3 trials, with the hype surrounding any potential covid treatment, it's a multifactorial decision to not put my money in.

I'm invested in a few aussie biotechs, some very small and risky. I'm not risk averse. I'm just cautious and try and be thorough.

But that's also why I missed out on an 80% gain over the last few days so who knows

GLTAH